Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-30 @ 9:20 PM
Study NCT ID:
NCT07410559
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-18
First Post:
2026-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-08
First Submit QC Date:
None
Study First Post Date:
2026-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-14
Last Update Post Date:
2026-02-18
Last Update Post Date Type:
ACTUAL